Abstract
The type II fatty acid synthase (FAS) pathway of Plasmodium falciparum is a validated unique target for developing novel antimalarials, due to its intrinsic differences from the typeI pathway operating in humans. beta-Ketoacyl acyl carrier protein (ACP) reductase (FabG) performs the NADPH-dependent reduction of beta-ketoacyl-ACP to beta-hydroxyacyl-ACP, the first reductive step in the elongation cycle of fatty acid biosynthesis. In this article, we report intensive studies on the direct interactions of Plasmodium FabG and Plasmodium ACP in solution, in the presence and absence of its cofactor, NADPH, by monitoring the change in intrinsic fluorescence of P.falciparum FabG (PfFabG) and by surface plasmon resonance. To address the issue of the importance of the residues involved in strong, specific and stoichiometric binding of PfFabG to P.falciparum ACP (PfACP), we mutated Arg187, Arg190 and Arg230 of PfFabG. The activities of the mutants were assessed using both an ACP-dependent and an ACP-independent assay. The affinities of all the PfFabG mutants for acetoacetyl-ACP (the physiological substrate) were reduced to different extents as compared to wild-type PfFabG, but were equally active in biochemical assays with the substrate a...Continue Reading
References
Jan 1, 1997·Annual Review of Biophysics and Biomolecular Structure·P Schuck
Nov 5, 1997·Analytical Biochemistry·L NiebaA Plückthun
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·R F WallerG I McFadden
Nov 6, 1998·Science·M J GardnerS L Hoffman
May 10, 2000·Structure·M FisherJ B Rafferty
Feb 15, 2001·Nature Medicine·N Surolia, A Surolia
Oct 24, 2001·Biochemistry·A C PriceS W White
Apr 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Valerie CampanacciChristian Cambillau
Aug 22, 2003·The Journal of Biological Chemistry·Shailendra Kumar SharmaAvadhesha Surolia
Oct 7, 2003·The Journal of Biological Chemistry·Yong-Mei ZhangCharles O Rock
Nov 26, 2003·Antimicrobial Agents and Chemotherapy·Shilpi SharmaNamita Surolia
May 6, 2004·The Biochemical Journal·Mili KapoorAvadhesha Surolia
Aug 19, 2004·The Biochemical Journal·Avadhesha SuroliaNamita Surolia
Dec 22, 2004·Chemistry & Biology·Andrzej WitkowskiStuart Smith
Apr 13, 2005·Biochemical and Biophysical Research Communications·Shailendra Kumar SharmaNamita Surolia
Jun 15, 2005·Annual Review of Biochemistry·Stephen W White Rock
Oct 18, 2005·The Biochemical Journal·Sasala R WickramasingheAlan H Fairlamb
Jun 1, 2006·Biochemistry·Alok Kumar SharmaSiddhartha P Sarma
Aug 29, 2006·The FEBS Journal·Krishanpal Karmodiya, Namita Surolia
Oct 25, 2006·Antimicrobial Agents and Chemotherapy·T N C RamyaAvadhesha Surolia
Dec 30, 2006·The Journal of Biological Chemistry·T N C RamyaNamita Surolia
Citations
Jun 13, 2009·The Journal of Biological Chemistry·Santosh Kumar UpadhyayMonica Sundd
Aug 30, 2012·Natural Product Reports·John Crosby, Matthew P Crump
Sep 16, 2011·Molecular BioSystems·Zhixia YeGavin J Williams
Dec 18, 2009·Journal of Molecular Recognition : JMR·Rebecca L Rich, David G Myszka